Chinese vaccine firm CanSino Biologic’s inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac’s shot, but the antibody level dropped in months, clinical trial data showed.
Western nations are working to lessen dependence on China as a supplier for ingredients and goods of all kinds, and China’s economy slowed significantly as a consequence of COVID-19 lockdowns, yet its biopharma sector appears strong. That’s because biotech is designated as a strategic emerging industry.
China will pay close attention to variants of coronavirus in the long term, focusing on their transmission capability, pathogenicity and ability to evade immunity, a Chinese disease control official said on Thursday.
Could WuXi AppTec and Pfizer-backed CStone Pharmaceuticals be snapped up by a larger pharma company? Rumors are circulating that executives with the China-based company are exploring strategic options that could include a sale of the company.
Multiple Chinese cities are adopting fresh COVID-19 curbs, from business halts to lockdowns, to rein in new infections, with the commercial hub of Shanghai bracing for another mass testing effort after finding a highly-transmissible Omicron subvariant.
Wuxi Biologics, a Chinese company that makes ingredients for AstraZeneca’s COVID-19 vaccine, may be a step closer to being taken off a U.S. trade list that it landed on five months ago, wiping HK$77 billion ($9.9 billion) off its market value at the time.
AstraZeneca had a very busy week of international news, with progress being shown in China, positive recommendations for two drugs in Europe, and a positive clinical trial update.
The World Health Organization said on Thursday its latest investigation into the origins of COVID-19 was inconclusive, largely because data from China is missing, another blow to the WHO’s years-long effort to determine how the pandemic began.
In the months before it acknowledged its first official COVID-19 outbreak, North Korea suddenly imported millions of face masks, 1,000 ventilators, and possibly vaccines from China, trade data released by Beijing showed.